

Developer of a needle-free vaccine delivery system. The company develops and commercializes a vaccine delivery technology which consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device.
Vaxxas was founded in 2011 and its current CEO is David Hoey. Since its inception 15 years ago, Vaxxas has grown to 17 employees.
| Headquarter | Suite 13.02, Level 13, Sydney 2000 Australia |
|---|---|
| Website | www.vaxxas.com |
| Founding Date | 2011 |
| Company Status | Private |
Vaxxas has 17 employees. 1 employee at Vaxxas has reviewed Vaxxas across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was months ago.

The prevailing opinion from Comparably users about their company is that it was very prepared on their first day. Employees concluded that their overall onboarding experience was positive. 73% said their direct manager was helpful with their acclimation during the first 90 days. First impressions are important, and how prepared a company is on your first day leaves a lasting impression.
At this moment no Vaxxas employees have provided insight into whether or not they clearly understand Vaxxas' KPIs and OKRs.

No Recent Jobs found for Vaxxas on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

What is Vaxxas address?
Vaxxas location is at Suite 13.02, Level 13, Sydney
Who is the CEO of Vaxxas?
Vaxxas CEO is David Hoey, their score by employees is 70
What is Vaxxas eNPS?
The eNPS for Vaxxas is -100
How many employees work in Vaxxas?
Vaxxas has 17 employees
Who is Vaxxas leadership?
are part of Vaxxas leadership, David Hoey is the CEO